-transparent.png){kind=logo}
Normal human complement serum (NHS) inhibited precipitin reactions between tetanus toxoid and human or rabbit anti-tetanus toxoid IgG antibody, between bovine serum albumin (BSA) and rabbit anti-BSA IgG antibody, and between hen egg albumin and rabbit anti-egg albumin IgG antibody. Ethylene-diaminetetraacetic acid (EDTA) prevented this inhibition. Mg-ethyleneglycol-bis(aminoethyl)-tetra-acetic acid-(EGTA) also prevented the inhibition except with lower concentrations of antibody and antigen. Therefore, the inhibition of immune precipitation seemed to occur mainly through the classical pathway of complement activation. The alternative pathway was usually dispensable, but it augmented the inhibition. Guinea pig complement serum (NGS) was less effective than NHS in inhibiting immune precipitation. Guinea pig serum deficient in C4 (C4DGS) did not inhibit the immune precipitation. Mouse complement serum was effective for inhibiting precipitation, and C5-deficient serum was as effective as normal serum. Therefore, the inhibition of immune precipitation is considered to occur by activation of complement up to the step of C3. The size of the soluble immune complexes formed in the presence of NHS varied depending on the concentrations of antibody and antigen, even when the ratio of antigen to antibody was constant. On incubation at 37 degrees C immune precipitation was inhibited by 1/2 dilution of NHS for 2 to 3 hr and then gradually increased to the level in the absence of complement. When the immune complexes were formed in the presence of serum containing complement, fragments of C4 and C3 were incorporated into the soluble immune complexes. The C3 fragments incorporated into the soluble complexes were C3b, iC3b, C3c, and C3d, some of which were bound covalently with heavy chains of IgG antibody molecules. Some of the covalent linkages between C3 fragments and IgG seemed to be destroyed by alkali treatment, but not by hydroxylamine treatment. The formation of covalent bonds between IgG and C3 and probably C4 was essential for inhibition of immune precipitation, because inhibitors of their formation, such as putrescine, cadaverine, and salicylhydroxamic acid, effectively prevented the inhibition of precipitation. When antigen and antibody reacted in the presence of mixtures of various combinations of isolated complement components, C1, C4, C2, and C3 showed maximal inhibition of immune precipitation, whereas factors I and H had little effect.
K Hong, and
Y Takata, and
K Sayama, and
H Kozono, and
J Takeda, and
Y Nakano, and
T Kinoshita, and
K Inoue
November 1980,
Clinical and experimental immunology,
K Hong, and
Y Takata, and
K Sayama, and
H Kozono, and
J Takeda, and
Y Nakano, and
T Kinoshita, and
K Inoue
January 1990,
Rheumatology international,
K Hong, and
Y Takata, and
K Sayama, and
H Kozono, and
J Takeda, and
Y Nakano, and
T Kinoshita, and
K Inoue
July 1984,
Immunology,
K Hong, and
Y Takata, and
K Sayama, and
H Kozono, and
J Takeda, and
Y Nakano, and
T Kinoshita, and
K Inoue
February 1983,
Clinical and experimental immunology,
K Hong, and
Y Takata, and
K Sayama, and
H Kozono, and
J Takeda, and
Y Nakano, and
T Kinoshita, and
K Inoue
March 1982,
Clinical and experimental immunology,
K Hong, and
Y Takata, and
K Sayama, and
H Kozono, and
J Takeda, and
Y Nakano, and
T Kinoshita, and
K Inoue
January 1981,
Allergie und Immunologie,
K Hong, and
Y Takata, and
K Sayama, and
H Kozono, and
J Takeda, and
Y Nakano, and
T Kinoshita, and
K Inoue
November 1984,
Clinical and experimental immunology,
K Hong, and
Y Takata, and
K Sayama, and
H Kozono, and
J Takeda, and
Y Nakano, and
T Kinoshita, and
K Inoue
May 1986,
Clinical and experimental immunology,
K Hong, and
Y Takata, and
K Sayama, and
H Kozono, and
J Takeda, and
Y Nakano, and
T Kinoshita, and
K Inoue
March 1982,
Clinical and experimental immunology,
K Hong, and
Y Takata, and
K Sayama, and
H Kozono, and
J Takeda, and
Y Nakano, and
T Kinoshita, and
K Inoue
February 1983,
Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology,
